Limestone Investment Advisors »

Liminatus Pharma shares owned by Limestone Investment Advisors

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by Limestone Investment Advisors from 13F filings

Historical chart of Limestone Investment Advisors investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by Limestone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by Limestone Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3k 23k 0.15

More positions owned by Limestone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Goldman Sachs Call Option (GS)
JPMorgan Chase & Co. Call Option (JPM)
Citigroup Com New Call Option (C)
Alphabet Cap Stk Cl A (GOOGL)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Netflix (NFLX)
Wells Fargo & Company Call Option (WFC)
Bank of America Corporation Call Option (BAC)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)

View all positions for Limestone Investment Advisors

Top funds holding Liminatus Pharma

Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
Nomura Holdings
Falcon Edge Capital
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital
Toronto-Dominion Bank

View all funds holding Liminatus Pharma